All In Biotech

Free tool

FAERS Monitor: Fylnetra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761084 or its brand name (Fylnetra, Pegfilgrastim-Pbbk). Reports on generic versions are filed under their own applications.

Reports

11,979

Serious

11,039

92% of reports

Hospitalization

6,045

Death reported

1,860

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • febrile neutropenia2,020
  • neutropenia1,176
  • pyrexia912
  • nausea854
  • fatigue828
  • off label use782
  • diarrhoea769
  • anaemia748
  • thrombocytopenia612
  • pneumonia535
  • vomiting529
  • death502
  • dyspnoea476
  • neuropathy peripheral436
  • decreased appetite363

Reports by year received

View as table
YearReports
200425
200535
200610
200738
200854
2009105
2010111
2011282
2012423
2013486
2014349
2015509
2016370
2017450
2018815
2019656
2020841
2021968
20221,069
20231,159
20241,335
20251,112
2026777

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,180 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal2,02055.152.9104,339
neutropeniaSignal1,17615.314.515,681
thrombocytopeniaSignal6129.78.94,740
neuropathy peripheralSignal4368.17.42,698
anaemiaSignal7486.96.43,794
pyrexiaSignal9124.64.42,635
pneumoniaSignal5352.92.7676
decreased appetiteSignal3632.72.5405
diarrhoeaSignal7692.12.0451
vomiting5292.01.8260
nausea8541.91.8374
fatigue8281.91.7346
off label use7821.61.5167
dyspnoea4761.51.475
death5021.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.